Figure 1.

Effects of SRC-1 bioportides on cancer and primary fibroblast cells. (A) Viability of MCF-7 cells; (B) Viability of FB188 cells. Cells were seeded in 96-well plates at a density of 3000 or 2000 cells/well, respectively, and treated after every 24 h with the indicated peptide concentrations. Viability of both cell types was monitored at day 3 via the WST-1 assay. The values shown represent the mean values of one experiment, carried out in triplicate (mean ± SD). In total, three independent experiments were performed.